Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports
Published in: Current Pulmonology Reports 1/2015

01-03-2015 | Sleeping and Breathing (T Lee-Chiong, Section Editor)

Obesity hypoventilation syndrome

Authors: Safal Shetty, Sairam Parthasarathy

Published in: Current Pulmonology Reports | Issue 1/2015

Login to get access

Abstract

Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive, and sleep-disordered breathing. Early diagnosis and treatment is important because delay in treatment is associated with significant mortality and morbidity. Available treatment options include noninvasive positive airway pressure (PAP) therapies and weight loss. There is limited long-term data regarding the effectiveness of such therapies. This review outlines the current concepts of clinical presentation and diagnostic and management strategies to help identify and treat patients with obesity hypoventilation syndromes.
Literature
1.
Flegal KM et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.PubMed
2.
Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med. 2005;118(9):948–56.PubMed
3.
Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc. 2008;5(2):218–25.PubMedCentralPubMed
4.
Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest. 2007;132(4):1322–36.PubMed
5.
Mokhlesi B et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):117–24.PubMed
6.
Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55(10):1347–62. discussion 1363-5.PubMed
7.
Bulbul Y et al. Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution. Ann Thorac Med. 2014;9(2):87–91.PubMedCentralPubMed
8.
Kaw R et al. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest. 2009;136(3):787–96.PubMed
9.••
Nowbar S et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116(1):1–7. Nowbar et al showed that OHS if untreated at hospital discharge is associated with a mortality of 23 % at 18 months, and this reduces to 3 % in adequately treated patients of OHS. Untreated OHS patients are also likely to require invasive mechanical ventilation and hence prolonged hospital stay.
10.
Resta O et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med. 2000;94(3):240–6.PubMed
11.
Trakada GP et al. Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath. 2010;14(4):381–6.PubMed
12.
Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med. 2001;95(8):693–6.PubMed
13.
Akashiba T et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med. 2006;45(20):1121–5.PubMed
14.
Golpe R, Jimenez A, Carpizo R. Diurnal hypercapnia in patients with obstructive sleep apnea syndrome. Chest. 2002;122(3):1100–1. author reply 1101.PubMed
15.
Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest. 2005;127(3):710–5.PubMed
16.
Hart N et al. Obesity hypoventilation syndrome: does the current definition need revisiting? Thorax. 2014;69(1):83–4.PubMed
17.
Polotsky M et al. Effects of leptin and obesity on the upper airway function. J Appl Physiol. 1985;112(10):1637–43.
18.
Rapoport DM et al. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the "Pickwickian syndrome”. Chest. 1986;89(5):62–-35.
19.
Kress JP et al. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160(3):883–6.PubMed
20.
Resta O et al. Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med. 2000;56(6):215–22.PubMed
21.
Piper AJ. Obesity hypoventilation syndrome—the big and the breathless. Sleep Med Rev. 2011;15(2):79–89.PubMed
22.
Behazin N et al. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol. 1985;108(1):p. 212–8.
23.
Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960;15:377–82.PubMed
24.
Pelosi P et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest. 1996;109(1):144–51.PubMed
25.
Zerah F et al. Effects of obesity on respiratory resistance. Chest. 1993;103(5):1470–6.PubMed
26.
27.
Pankow W et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol. 1985;85(4):1236–43.
28.
Steier J et al. Neural respiratory drive in obesity. Thorax. 2009;64(8):719–25.PubMed
29.
Yap JC et al. Effects of posture on respiratory mechanics in obesity. J Appl Physiol. 1985;79(4):p. 1199-–205.
30.
Ferretti A et al. Expiratory flow limitation and orthopnea in massively obese subjects. Chest. 2001;119(5):1401–8.PubMed
31.
Lee MY et al. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration. 2009;77(2):146–53.PubMed
32.
Lin CC et al. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol. 2004;139(2):215–24.PubMed
33.
Chlif M et al. Effects of obesity on breathing pattern, ventilatory neural drive and mechanics. Respir Physiol Neurobiol. 2009;168(3):198–202.PubMed
34.
Pankow W et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J. 1997;10(12):2847–52.PubMed
35.
Sampson MG, Grassino AE. Load compensation in obese patients during quiet tidal breathing. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(4):1269–76.PubMed
36.
Kessler R et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest. 2001;120(2):369–76.PubMed
37.
Berg G et al. The use of health-care resources in obesity-hypoventilation syndrome. Chest. 2001;120(2):377–83.PubMed
38.
Borel JC et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One. 2009;4(8):e6733.PubMedCentralPubMed
39.
Masa JF et al. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest. 1997;112(1):207–13.PubMed
40.
Rochester DF, Enson Y. Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors. Am J Med. 1974;57(3):402–20.PubMed
41.
Sharp JT, Druz WS, Kondragunta VR. Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea. Am Rev Respir Dis. 1986;133(1):32–7.PubMed
42.
Jonville S, Delpech N, Denjean A. Contribution of respiratory acidosis to diaphragmatic fatigue at exercise. Eur Respir J. 2002;19(6):1079–86.PubMed
43.
Monneret D et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res. 2010;20(2):127–33.PubMed
44.
BaHammam A. Acute ventilatory failure complicating obesity hypoventilation: update on a ‘critical care syndrome’. Curr Opin Pulm Med. 2010;16(6):543–51.PubMed
45.
Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75(1):81–90.PubMed
46.
Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis. 1982;126(4):640–5.PubMed
47.
Macavei VM et al. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med. 2013;9(9):879–84.PubMedCentralPubMed
48.
Zwillich CW et al. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med. 1975;59(3):343–8.PubMed
49.
Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005–10.PubMed
50.
de Lucas-Ramos P et al. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med. 2004;98(10):961–7.PubMed
51.
Berthon-Jones M, Sullivan CE. Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis. 1987;135(1):144–7.PubMed
52.
Han F et al. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2001;119(6):1814–9.PubMed
53.
Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006;130(3):827–33.PubMed
54.
Berger KI et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest. 2001;120(4):1231–8.PubMed
55.
Caro JF et al. Leptin: the tale of an obesity gene. Diabetes. 1996;45(11):1455–62.PubMed
56.
57.
Shimura R et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(2):543–9.PubMed
58.
Tatsumi K et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(3):716–21.PubMed
59.
O'Donnell CP et al. Leptin, obesity, and respiratory function. Respir Physiol. 2000;119(2–3):163–70.PubMed
60.
Campo A et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J. 2007;30(2):223–31.PubMed
61.
Tankersley CG et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol. 1985;85(6):p. 2261–9.
62.
Huang K et al. Effects of leptin deficiency on postnatal lung development in mice. J Appl Physiol. 1985;105(1):p. 249–59. 2008.
63.
Basoglu OK, Tasbakan MS. Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J. 2014;8(2):167–74.PubMed
64.
Manuel A.R., N. Hart and J.R. Stradling, Is a raised bicarbonate, without hypercapnia, part of the physiological spectrum of obesity-related hypoventilation? Chest, 2014.
65.
Combs D, Shetty S, Parthasarathy S. Advances in positive airway pressure treatment modalities for hypoventilation syndromes. Sleep Med Clin. 2014;9(3):315–25.PubMed
66.••
Carrillo A et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(12):1279–85. Carrillo et al. conducted a study aimed at assessing the efficacy of NIPPV in OHS patients during an episode of AHRF with the hypothesis that they would respond similarly to patients with COPD with a similar presentation. The results of the study suggest that patients with OHS in AHRF respond more favorably to NIPPV with improved outcomes, gas exchange, and mortality than patients with COPD.
67.
Kelly JL et al. Randomized trial of 'intelligent' autotitrating ventilation versus standard pressure support non-invasive ventilation: impact on adherence and physiological outcomes. Respirology. 2014;19(4):596–603.PubMed
68.
Held M et al. Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation. Eur Respir J. 2014;43(1):156–65.PubMed
69.
Kawata N et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest. 2007;132(6):1832–8.PubMed
70.
Piper AJ et al. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395–401.PubMed
71.
Hida W et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath. 2003;7(1):3–12.PubMed
72.
Banerjee D et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007;131(6):1678–84.PubMed
73.
Salord N et al. Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea. Respirology. 2013;18(7):1135–42.PubMed
74.
Janssens JP et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest. 2003;123(1):67–79.PubMed
75.
Masa JF et al. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest. 2001;119(4):1102–7.PubMed
76.
Perez de Llano LA et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest. 2005;128(2):587–94.PubMed
77.
Priou P et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest. 2010;138(1):84–90.PubMed
78.
Chouri-Pontarollo N et al. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest. 2007;131(1):148–55.PubMed
79.
Storre JH et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest. 2006;130(3):815–21.PubMed
80.
Redolfi S et al. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med. 2007;101(6):1191–5.PubMed
81.
Windisch W. Quality of life in home mechanical ventilation study group. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J. 2008;32(5):p. 1328–36.
82.
Borel JC et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692–702.PubMed
83.
Rabec C et al. Ventilator modes and settings during non-invasive ventilation: effects on respiratory events and implications for their identification. Thorax. 2011;66(2):170–8.PubMed
84.
Berry RB et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med. 2010;6(5):491–509.PubMed
85.
Contal O et al. Impact of different backup respiratory rates on the efficacy of noninvasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest. 2013;143(1):37–46.PubMed
86.
87.
Ambrogio C et al. Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency. Intensive Care Med. 2009;35(2):306–13.PubMed
88.
Amato MB et al. Volume-assured pressure support ventilation (VAPSV). A new approach for reducing muscle workload during acute respiratory failure. Chest. 1992;102(4):1225–34.PubMed
89.
Murphy PB et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67(8):727–34.PubMed
90.
Hollier CA et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69(4):346–53.PubMed
91.
Wijesinghe M et al. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011;139(5):1018–24.PubMed
92.
Mokhlesi B, Tulaimat A, Parthasarathy S. Oxygen for obesity hypoventilation syndrome: a double-edged sword? Chest. 2011;139(5):975–7.PubMed
93.
Heinemann F et al. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med. 2007;101(6):1229–35.PubMed
94.••
Budweiser S et al. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375–83. Budweiser et al. performed a retrospective analysis on patients with OHS on NIPPV to assess the long-term survival and predictors of mortality. In patients who were receiving NIPPV at home, they found significant improvement in arterial blood gases and lung volumes. During the mean observation time of 41.3 months, the all-cause mortality was 12.7 %. After 1, 2, and 3 years, the survival was 97, 92, and 70%.
95.
Hawrylkiewicz I et al. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis. 2004;61(3):148–52.PubMed
96.
Chaouat A et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J. 1997;10(8):1730–5.PubMed
97.
Fletcher EC et al. Exercise hemodynamics and gas exchange in patients with chronic obstruction pulmonary disease, sleep desaturation, and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1989;140(5):1237–45.PubMed
98.
Castro-Anon O et al. Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome. Respirology. 2012;17(8):1269–74.PubMed
99.
Masa Jimenez JF et al. Nasal intermittent positive pressure ventilation. Analysis of its withdrawal. Chest. 1995;107(2):382–8.PubMed
100.
De Miguel Diez J et al. Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results. Arch Bronconeumol. 2003;39(7):292–7.PubMed
101.
McArdle N et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1108–14.PubMed
102.
Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev. 2003;7(1):81–99.PubMed
103.
Mokhlesi B et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med. 2006;2(1):57–62.PubMedCentralPubMed
104.
Borel JC et al. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One. 2013;8(1):e52006.PubMedCentralPubMed
105.
Sugerman HJ et al. Gastric surgery for respiratory insufficiency of obesity. Chest. 1986;90(1):81–6.PubMed
106.
107.
Vaughan RW, Cork RC, Hollander D. The effect of massive weight loss on arterial oxygenation and pulmonary function tests. Anesthesiology. 1981;54(4):325–8.PubMed
108.
Weiner P et al. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax. 1998;53(1):39–42.PubMedCentralPubMed
109.
Boone KA et al. Impact of vertical banded gastroplasty on respiratory insufficiency of severe obesity. Obes Surg. 1996;6(6):454–8.PubMed
110.
Dixon JB et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142–9.PubMed
111.
Gloy VL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedCentralPubMed
112.
Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMed
113.
Sugerman HJ et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55(2 Suppl):597S–601.PubMed
114.
Piper AJ, Grunstein RR. Current perspectives on the obesity hypoventilation syndrome. Curr Opin Pulm Med. 2007;13(6):490–6.PubMed
115.
Lumachi F et al. Hypoxemia and hypoventilation syndrome improvement after laparoscopic bariatric surgery in patients with morbid obesity. In Vivo. 2010;24(3):329–31.PubMed
116.
De Cesare A et al. Early and long-term clinical outcomes of bilio-intestinal diversion in morbidly obese patients. Surg Today. 2014;44(8):1424–33.PubMed
117.
Marti-Valeri C et al. Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obes Surg. 2007;17(8):1102–10.PubMed
118.
Ashrafian H et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures. Thorax. 2012;67(5):442–9.PubMed
119.
Kim SH et al. Evaluation of patients with sleep apnea after tracheotomy. Arch Otolaryngol Head Neck Surg. 1998;124(9):996–1000.PubMed
120.
Sullivan CE et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–5.PubMed
121.
El Solh AA, Jaafar W. A comparative study of the complications of surgical tracheostomy in morbidly obese critically ill patients. Crit Care. 2007;11(1):R3.PubMedCentralPubMed
122.
Teppema LJ, Dahan A. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med. 1999;160(5 Pt 1):1592–7.PubMed
123.
Wagenaar M et al. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest. 2003;123(5):1450–9.PubMed
124.
Kiwull-Schone HF, Teppema LJ, Kiwull PJ. Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Am J Respir Crit Care Med. 2001;163(2):478–83.PubMed
125.
van de Ven MJ et al. Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD. Chest. 2002;121(2):383–92.PubMed
126.
Vos PJ et al. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J. 1994;7(5):850–5.PubMed
127.
Swenson ER, Hughes JM. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol. 1985;74(1):p. 230–7. 1993.
128.
Powers MA. Obesity hypoventilation syndrome: bicarbonate concentration and acetazolamide. Respir Care. 2010;55(11):1504–5.PubMed
129.
Mason M, Welsh EJ, Smith I. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2013;5, CD003002.PubMed
130.
Parthasarathy S, Subramanian S, Quan SF. A multicenter prospective comparative effectiveness study of the effect of physician certification and center accreditation on patient-centered outcomes in obstructive sleep apnea. J Clin Sleep Med. 2014;10(3):1–7.
Metadata
Title
Obesity hypoventilation syndrome
Authors
Safal Shetty
Sairam Parthasarathy
Publication date
01-03-2015
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 1/2015
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-015-0108-6

Other articles of this Issue 1/2015

Current Pulmonology Reports 1/2015 Go to the issue

Interventional Pulmonology (S Maceiras-Luis, Section Editor)

Indwelling pleural catheters

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

IgG4-related pleural disease

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Discovery of new biomarkers for malignant mesothelioma

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Sleep disorders in COPD

Pleural Diseases and Mesothelioma (C Gary Lee, Section Editor)

Adjunct strategies to enhance the efficacy of indwelling pleural catheters

Sleeping and Breathing (T Lee-Chiong, Section Editor)

Sleep-disordered breathing as a modifiable risk factor for cardiovascular disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits